Bryan Johnson said last week that he has autoimmune gastritis, a diagnosis he said came in May after years of persistently low ferritin. He described the condition as causing “irreversible damage” to the lining of the stomach.
The disclosure adds a medical explanation for a lab pattern his team had struggled to explain for years. Emeka Okeke said autoimmune gastritis is “not fatal,” but he also said it does not have a cure and can increase the long-term risk of developing stomach cancer.
Bryan Johnson and May diagnosis
Johnson said the condition often develops silently and asymptomatically over the course of years, which fits the long gap between the low ferritin readings and the diagnosis in May. The timeline matters because the disorder can remain hidden while damage continues inside the stomach lining.
That sequence also puts his case in sharper focus. Bryan Johnson has built a public image around close tracking of his biology, yet he said a chronic autoimmune disease went unidentified for years while a basic iron marker stayed low.
Emeka Okeke on autoimmune causes
Okeke said, “For most autoimmune diseases, the etiology is unknown, although we know that there are environmental and genetic factors that indicate who would have greater susceptibility.” He added that autoimmune diseases can arise “de novo” without any known cause.
He also said “inherited genes and environmental triggers, but also potentially infections, can set the disease process in motion.” Gian Corrado said autoimmune disorders are quite common, even among apparently healthy and fit individuals, which fits Johnson’s own description of living with the condition despite years of attention to health metrics.
Northeastern University context
The diagnosis arrives amid growing public interest in longevity medicine and therapies, the same space Johnson has occupied for years. Johnson claims to have spent millions of dollars tracking and streamlining nearly every aspect of his biology, and he purports to get more than eight hours of sleep each night and to have a fertility age in his early twenties.
For readers facing unexplained low ferritin or other persistent lab changes, the practical lesson is direct: a long-running abnormal result can point to a condition that may not announce itself with obvious symptoms. In Johnson’s case, the central fact remains the diagnosis he said he received in May, and the unresolved question is what set the disease process in motion.
